Showing results (1201-1210 of 5,345) with videos related to

Sort By:
Pageof 535
Japanese Journal of Clinical Oncology|December 1, 1987
Pulmonary reaction to an aspirated balanced liquid diet in a cancer patientM Yamashina, F Moatamed
Japanese Journal of Clinical Oncology|August 20, 2021
Current status of medical oncology in Japan and changes over the most recent 7-year period: results of a questionnaire sent to designated cancer care hospitalsMakoto Arai, Izumi Ohno, Koji Takahashi, et al.
Japanese Journal of Clinical Oncology|August 17, 2022
Aggressive histological component in subsolid lung adenocarcinoma: priority for resection without delayMasaya Yotsukura, Kazuo Nakagawa, Chihiro Takemura, et al.
Japanese Journal of Clinical Oncology|August 17, 2022
Medical management of older patients with lung cancerYoshitaka Zenke, Taiki Hakozaki, Yoshiro Nakahara, et al.
Japanese Journal of Clinical Oncology|December 5, 2025
Changing treatment outcomes in metastatic and recurrent pancreatic cancer: a real-world comparison before and after the availability of nanoliposomal irinotecanTakafumi Mie, Masato Ozaka, Takeshi Okamoto, et al.
Japanese Journal of Clinical Oncology|December 16, 2025
Protocol digest of a randomized phase III study of pola-R-CHP/high-dose methotrexate/IT vs. pola-R-CHP/IT for newly diagnosed diffuse large B-cell lymphoma with high risk of central nervous system relapse: JCOG2201 (PREMIER)Yusuke Sano, Kana Miyazaki, Motoko Yamaguchi, et al.
Japanese Journal of Clinical Oncology|December 2, 2025
Trends in usage and drug costs of immune checkpoint inhibitors in JapanAkina Takami, Koki Yamashita, Ataru Igarashi
Japanese Journal of Clinical Oncology|January 21, 2026
Depth-oriented organ-preserving salvage endoscopic strategy with argon plasma coagulation and photodynamic therapy for residual or recurrent esophageal squamous cell carcinoma after chemoradiotherapyNaomi Fukagawa, Yasuaki Furue, Chikatoshi Katada, et al.
Japanese Journal of Clinical Oncology|January 24, 2026
Triplet therapy versus androgen receptor pathway inhibitor-doublet therapy in metastatic castration-sensitive prostate cancer: a real-world multicenter retrospective comparisonFumihiko Urabe, Takafumi Yanagisawa, Wataru Fukuokaya, et al.
Japanese Journal of Clinical Oncology|January 25, 2026
Safety and effectiveness of selpercatinib in patients with RET fusion-positive non-small cell lung cancer in real-world clinical practice: a postmarketing study in JapanYucherng Chen, Joji Mori, Satoshi Wakabayashi, et al.
Pageof 535